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The small GTPases Rac1 and Cdc42 are key regulators of the morphogenesis of actin-rich dendritic spines in neurons. However, little is
known about how activated Rac1/Cdc42 regulates dendritic spines. Insulin receptor substrate 53 (IRSp53), which is highly expressed in
the postsynaptic density (PSD), is known to link activated Rac1/Cdc42 to downstream effectors for actin regulation in non-neural cells.
Here, we report that IRSp53 interacts with two specific members of the PSD-95 family, PSD-95 and chapsyn-110/PSD-93, in brain. An
IRSp53 mutant lacking the C-terminal PSD-95-binding motif shows significant loss of synaptic localization in cultured neurons. Over-
expression of IRSp53 in cultured neurons increases the density of dendritic spines but does not affect their length or width. Conversely,
short-interfering RNA-mediated knock-down of IRSp53 reduces the density, length, and width of spines. In addition, the density and size
of spines are decreased by a dominant-negative IRSp53 with a point mutation in the Src homology 3 (SH3) domain and a dominant-
negative proline-rich region of WAVE2 (Wiskott-Aldrich syndrome protein family Verprolin-homologous protein), a downstream effec-
tor of IRSp53 that binds to the SH3 domain of IRSp53. These results suggest that PSD-95 interaction is an important determinant of
synaptic IRSp53 localization and that the SH3 domain of IRSp53 links activated Rac1/Cdc42 to downstream effectors for the regulation of
spine morphogenesis.
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Introduction
Dendritic spines are postsynaptic actin-rich protrusions impli-
cated in the regulation of the structure, function, and plasticity of
glutamatergic synapses (Harris and Kater, 1994; Matus, 2000;
Hering and Sheng, 2001; Yuste and Bonhoeffer, 2001, 2004; Nim-
chinsky et al., 2002). Synaptic molecules that have received atten-
tion for their roles in regulating spine morphogenesis include the
Rac1 and Cdc42 Rho family of small GTPases (Luo et al., 1996;
Nakayama et al., 2000; Tashiro et al., 2000; Irie and Yamaguchi,
2002; Scott et al., 2003) and their upstream activators, including
the Kalirin-7 and p21-activated kinase (PAK) interacting ex-
change factor (PIX) guanine nucleotide exchange factors (Pen-
zes et al., 2000, 2001, 2003; Parnas et al., 2001; Park et al., 2003;
Zhang et al., 2003). However, the molecular mechanisms linking
activated Rac1/Cdc42 to downstream effectors for spine regula-
tion are not well understood.
Insulin receptor substrate 53 (IRSp53) is an effector protein
that couples activated Rac1/Cdc42 to actin regulation (Miki et al.,
2000; Govind et al., 2001; Krugmann et al., 2001). IRSp53 con-
tains various domains for protein–protein interaction, including
an N-terminal Rac binding (RCB) domain, a partial Cdc42 and
Rac1-interactive binding (CRIB) motif, an Src homology 3 (SH3)
domain, and a C-terminal PDZ [postsynaptic density-95 (PSD-
95)/Discs large/zona occludens-1 (ZO-1)]-binding motif. The
RCB domain of IRSp53 binds activated Rac1, stimulating forma-
tion of lamellipodia and ruffles by mechanisms requiring the
interaction of its SH3 domain with WAVE2 (Wiskott-Aldrich
syndrom protein family Verprolin-homologous protein), a
member of the Wiskott-Aldrich syndrome protein (WASP) fam-
ily of actin-regulatory proteins (Miki et al., 2000; Miki and Tak-
enawa, 2002). The partial CRIB motif of IRSp53 binds activated
Cdc42 and induces the formation of filopodia through the inter-
action of its SH3 domain with Mena, a member of the Ena/
vasodilator-stimulated phosphoprotein family of actin-
regulatory proteins (Govind et al., 2001; Krugmann et al., 2001).
The SH3 domain of IRSp53 also associates with various poly-
proline-containing proteins, including the abundant PSD pro-
tein Shank/Proline-rich synapse-associated protein (SAP) (Bock-
mann et al., 2002; Soltau et al., 2002), the actin-bundling protein
espin (Sekerkova et al., 2003), and mDia1, a regulator of stress
fiber formation and cytokinesis (Fujiwara et al., 2000). The
C-terminal PDZ-binding motif binds to the PDZ domain protein
MALS (mammalian LIN-seven) (Hori et al., 2003). Recently, the
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N-terminal domain of IRSp53 (IMD) (overlaps with the RCB
domain) was shown to induce filopodia independent of the SH3
domain, which is under the tight control of Rac1/Cdc42 (Yam-
agishi et al., 2004). These results suggest that IRSp53 is an impor-
tant Rac1/Cdc42-dependent regulator of the actin cytoskeleton.
In neurons, IRSp53 was initially identified as a component of the
PSD (Abbott et al., 1999), but little is known about its neuronal
functions. Important steps toward understanding the neuronal
functions of IRSp53 would be to determine the molecular mecha-
nism by which IRSp53 is localized to the PSD and whether and how
IRSp53 regulates the morphogenesis of dendritic spines. Here, we
report that the interaction of IRSp53 with PSD-95, an abundant PSD
protein, is important for synaptic IRSp53 localization and that
IRSp53, through its SH3 domain, regulates spine morphogenesis.
Materials and Methods
Yeast two-hybrid screen and assay. The PDZ2 domain of PSD-95 (aa
89 –299) in the pBHA bait vector was used to screen a human brain yeast
two-hybrid cDNA contained in the pACT2 prey vector (Clontech, Palo
Alto, CA). IRSp53 (aa 438 –521) and a mutant of aa 438 –521 in which the
last Val residue was changed to Ala were subcloned into the EcoRI-
BamHI site of pBHA. PDZ12 (aa 124363) and PDZ3 (aa 384523) of
mouse SAP102 and PDZ12 (aa 1–272) of human ZO-1 were subcloned
into the BamHI-EcoRI site of pGAD10. Other PDZ domains in pGAD10
have been described previously (Choi et al., 2002; Mok et al., 2002).
GST pull-down assay. For glutathione S-transferase (GST) fusion pro-
teins, aa 470 –521 and 470 –517 of IRSp53 and aa 786 – 899 of Shank1
were subcloned into the BamHI-EcoRI site of pGEX4T-1 (Amersham
Biosciences, Arlington, IL). The precipitates were analyzed by immuno-
blotting with antibodies against Myc (1 g/ml; for PSD-95 and chapsyn-
110), enhanced green fluorescent protein (EGFP) [1 g/ml; SAP97 and
S-SCAM (synaptic scaffolding molecule)], FLAG (1 g/ml; SAP102),
and IRSp53 (1 g/ml) antibodies.
Antibodies. H6-IRSp53 (human full length) was used as an immuno-
gen to generate rabbit (1452) and guinea pig (1454) polyclonal antibod-
ies. Guinea pig polyclonal PSD-95 (1402) and rabbit polyclonal SAP102
(1445) antibodies were generated using GST-PSD-95 (rat full length) and
GST-SAP102 (mouse full length) as immunogens, respectively. Specific
antibodies were affinity purified using polyvinylidene difluoride mem-
branes (Amersham Biosciences) or SulfoLink columns (Pierce, Rock-
ford, IL), and the specificity of each antibody for the corresponding
PSD-95 family protein was confirmed by immunoblot analysis (data not
shown). The following antibodies have been described previously:
PSD-95 (HM319) (Kim et al., 1995), PSD-95 (SM55) (Choi et al., 2002),
SAP97 (B9591) (Kim et al., 1996), chapsyn-110 (B9594) (Kim et al.,
1996), S-SCAM (1146) (Mok et al., 2002), EGFP (1167) (Choi et al.,
2002), NMDA receptor subunit 2B (NR2B) (Sheng et al., 1994), Shank
(3856) (Naisbitt et al., 1999), and Shank (1123) (Lim et al., 2001). The
following antibodies were purchased: synaptophysin, FLAG, -tubulin,
and vinculin hVIN-1 (Sigma, St. Louis, MO); HA mouse monoclonal
(Boehringer Mannheim, Philadelphia, PA); and HA and Myc rabbit
polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA).
Expression and short-interfering RNA constructs. Human IRSp53
cDNAs (NM_017450; full length aa 1–521 and aa 1–517, which lacks the
last four residues) were subcloned into the BamHI-EcoRI site of
pcDNA3.1-HA (the HA epitope was inserted into the HindIII-KpnI site
of pcDNA3.1, which is located N terminal to the site of IRSp53 insertion)
for coimmunoprecipitation in heterologous cells and targeting experi-
ments in neurons) and the BglII-EcoRI site of pIRES2-EGFP (for spine-
promoting experiments in neurons; Clontech). Full-length rat IRSp53
(AY037934) was subcloned into the BamHI-EcoRI site of pcDNA3.1-HA
[for the analysis of short-interfering RNA (siRNA) constructs]. Mouse
SAP102 (full length; aa 1– 835) was subcloned into the HindIII-EcoRI site
of the pFLAG-CMV2 vector (Sigma). Full-length SAP97 (rat; aa 1–912)
and S-SCAM (rat; aa 1–1278) were subcloned into the EcoRI-KpnI site of
pEGFP-N1 (Clontech). For siRNA downregulation, pSUPER IRSp53
was generated by annealing oligonucleotides containing nt 522–540
(with the first nucleotide of the start codon as nucleotide 1) of the rat
IRSp53 cDNA (GenBank accession number AY037934; critical 19 nucle-
otide sequence GCTGGAGAACTACGTGTCT) and subcloning into the
BglII-HindIII site of pSUPER (OligoEngine Platform, Seattle, WA). For
FLAG-WAVE2 Pro, aa 273– 402 of WAVE2 was subcloned into the
HindIII-KpnI site of p3XFLAG-CMV7.1 (Sigma). IRSp53 constructs
with a point mutation in the SH3 domain (I403P) were generated using
the QuickChange kit (Stratagene, La Jolla, CA). The following expression
constructs have been described previously: GW1-PSD-95-EGFP (Arnold
and Clapham, 1999), GW1-Myc-PSD-95 (Hsueh et al., 1997), and GW1-
Myc-chapsyn-110 (Hsueh et al., 1997).
Preparation and immunoblot analysis of PSD and subcellular fractions.
Subcellular fractionation of rat brain was performed as described previ-
ously (Huttner et al., 1983). PSD fractions were purified as described
previously (Cho et al., 1992). Immunoblot analysis of these fractions was
performed using IRSp53 (1452; 1 g/ml), PSD-95 (SM55; 1:500), and
synaptophysin (1:1000) antibodies.
Coimmunoprecipitation assay. For coimmunoprecipitation with brain
samples, the crude synaptosomal fraction of adult rat brain was solubi-
lized with deoxycholic acid (DOC) buffer (50 mM Tris-HCl, 1% sodium
deoxycholate, pH 9.0), dialyzed against binding/dialysis buffer (50 mM
Tris-HCl, 0.1% Triton X-100, pH 7.4), and centrifuged. The supernatant
was incubated with PSD-95 (1402; 1 g/ml), IRSp53 (1452; 2 g/ml), or
rabbit/guinea pig IgG (2 g/ml; negative control) for 2 h and then with
protein A-Sepharose (Amersham Biosciences) for 2 h. The precipitates
were analyzed by immunoblotting with antibodies against IRSp53 (1452
and 1454; 1 g/ml), NR2B (1:1000), vinculin (1:1000), PSD-95 (HM319;
1:1000), chapsyn-110 (B9594; 1:1000), SAP97 (B9591; 1:1000), SAP102
(1445; 1:1000), S-SCAM (1146; 1:1000), and Shank (3856; 1:1000).
Immunofluorescence histochemistry on rat brain sections. Rat brain sec-
tions (50 m) were permeabilized by incubation in PBS containing 50%
ethanol at room temperature for 30 min. For immunofluorescence stain-
ing, brain sections were doubly incubated with IRSp53 (1:500) and syn-
aptophysin (1:1000) antibodies or NeuroTrace fluorescent Nissl stain
(1:1000; Molecular Probes) overnight at room temperature, followed
by FITC- and CY3-conjugated secondary antibodies (Jackson Immuno-
Research, West Grove, PA) for 2 h at room temperature. Images were
captured using a Leica (Nussloch, Germany) SP2 confocal laser-scanning
microscope.
Immunoelectron microscopy. Rat brain coronal sections (50 m thick)
were cut with a Vibratome and then washed in phosphate buffer (PB);
free-floating sections were treated with NaBH4 and locked with normal
goat serum (NGS; 10%) in PBS, pH 7.4, followed by incubations in the
primary and secondary antibodies. Rabbit anti-IRSp53 antibodies (num-
ber 1452) were used at 2 g/ml diluted in PBS containing 2% NGS. After
several washes, sections were treated with a blocking solution containing
5% BSA (Sigma), 0.1% BSA-c (Aurion, Wageningene, The Netherlands),
and 5% NGS (Jackson ImmunoResearch), followed by gold-conjugated
goat anti-rabbit IgG (Fab coupled to 1 nm gold particles, Electron
Microscopy Sciences, Fort Washington, PA; diluted 1:50 in PBS contain-
ing 2% NGS). After postfixation with 2% glutaraldehyde, sections were
rinsed in 0.1 M sodium acetate, and gold particles were silver-enhanced
using IntenseS-EM Silver (Amersham Biosciences). After several washes
in sodium acetate and PB, sections were postfixed with 0.5% OsO4, con-
trasted in 1% uranyl acetate in maleate buffer, dehydrated, and embed-
ded with epoxy resin (Epon/Spurr; Electron Microscopy Sciences). No
specific immunoreactivity could be detected when either the primary or
the secondary antibody was omitted before silver enhancement. For elec-
tron microscopy (EM), 70 nm thin sections were cut on a Leica ultra-
microtome, mounted on 200 mesh copper grids, contrasted with uranyl
acetate and Sato’s lead, and then examined in a Philips Tecnai electron
microscope at 80 kV. Digital micrographs were acquired with a Gatan
(Pleasanton, CA) 12-bit 1024  1024 CCD camera. Contrast, density,
and sharpness of final images for plates were adjusted using Adobe Pho-
toshop CS (Adobe Systems, San Jose, CA).
Primary neuron culture, transfection, and immunocytochemistry. Cul-
tured hippocampal neurons were prepared from embryonic day 18 (E18)
rat brain as described previously (Goslin and Banker, 1991). Cultures
were plated on coverslips (Fisher Scientific, Houston, TX) coated with
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poly-D-lysine (30 g/ml). Cultures were grown in Neurobasal medium
(Invitrogen, San Diego, CA) supplemented with B27 (Invitrogen), 0.5
mM glutamine, and 12.5 M glutamate. Low-density cultures were used
for colocalization studies. At 21 d in vitro (DIV), hippocampal neurons
were fixed in PBS containing 4% paraformaldehyde, permeabilized in
PBS containing 0.2% Triton X-100, and incubated with primary anti-
bodies against IRSp53 (1452; 2 g/ml) and PSD-95 (HM319; 3 g/ml),
followed by Cy3- or FITC-conjugated secondary antibodies. To deter-
mine the synaptic localization of IRSp53 proteins, neurons at a medium-
high density were transfected with HA-IRSp53 [wild type (WT) or mu-
tant] plus PSD-95-EGFP at 17 DIV using the calcium phosphate method
and stained at 19 DIV by double immunofluorescence staining with HA
monoclonal (for IRSp53; 1 g/ml) and EGFP (for PSD-95; 1:1000) anti-
bodies. To determine the effects of IRSp53/WAVE2 constructs on den-
dritic spines, neurons at 13–15 DIV were transfected with the indicated
cDNA constructs and visualized at 16 –17 DIV by double immunofluo-
rescence staining with IRSp53 (1452; 2 g/ml), EGFP (1:1000), and
Shank (1123; 1:200) antibodies.
Image acquisition and quantification. Fluorescent images were ac-
quired using a confocal microscope (LSM510; Zeiss, Oberkochen, Ger-
many). The same parameter settings were used for all scans. Each exper-
iment was repeated three to five times, and neuronal images for analysis
were randomly selected. Morphometric measurements were performed
using MetaMorph image analysis software (Universal Imaging, West
Chester, CA) and in part by a blind manner. To determine the synaptic
localization of IRSp53, the immunofluorescence intensity of a PSD-95-
positive spine was compared with that of an adjacent dendritic trunk.
The intensity ratios of spine to dendrite were obtained from a total of
400 measurements (15–20 neurons and 20 spines/trunks per neuron).
For the analysis of spine density, spines were defined as dendritic protru-
sions of 0.5–3 m length, with or without a head. Spine density was
measured by counting the number of spines on 10 –12 neurons (100
m total dendritic length per neuron). For spine dimensions, 300 –500
spines (10 –12 neurons) were measured for each condition. The length of
each spine was measured by manually drawing a vertical line from the
base of the neck to the furthest point on the spine head. Spine width was
measured by drawing a maximal line perpendicular to the length line in
the spine head. The density and dimensions of spines from a single neu-
ron were grouped and averaged; means from multiple individual neu-
rons were averaged to obtain a population mean and SEM. Statistical
significance was determined by Student’s t test.
Results
IRSp53 interacts with PSD-95 family proteins in vitro
PSD-95 is a key component of the PSD. To identify proteins that
contribute to the PSD-95-dependent organization of postsynap-
tic protein complexes, we searched for binding partners of
PSD-95 using the second PDZ domain (aa 89 –299) of PSD-95 as
bait and a human brain yeast two-hybrid cDNA library. One set
of positive clones contained overlapping fragments of IRSp53
that end with Ser-Thr-Val, a potential class I PDZ domain-
binding motif (Sheng and Sala, 2001). In the yeast two-hybrid
assay, IRSp53 interacted with the first two PDZ domains of all
known isoforms of the PSD-95 family (PSD-95/SAP90, SAP97,
chapsyn-110/PSD-93, and SAP102) and the S-SCAM multi-PDZ
protein but not with the PDZ domains of Shank1 and ZO-1 (Fig.
1A). A point mutation at the C-terminal residue of IRSp53
(Val521 to Ala) eliminated these interactions (Fig. 1A), suggest-
ing that IRSp53 interacts with PSD-95 through the canonical
PDZ interaction. In a GST pull-down assay, GST-IRSp53 (aa
470 –521), but not GST-IRSp53 lacking the last four residues (aa
470 –517) or GST alone, brought down all known PSD-95 family
proteins and S-SCAM expressed in heterologous cells (Fig. 1B).
In a coimmunoprecipitation analysis in heterologous cells, full-
length IRSp53 (IRSp53WT), but not the IRSp53 mutant lacking
the last four residues (IRSp53C), formed a complex with all
known PSD-95 family proteins and S-SCAM (Fig. 1C–G).
Singly transfected PSD-95 family proteins and S-SCAM were not
immunoprecipitated in control experiments (Fig. 1C–G, lane 4).
The overall coimmunoprecipitation efficiencies, however, were not
high, 1–2% of the inputs (Fig. 1C–G). Together, these results sug-
gest that IRSp53 associates with all known members of the PSD-95
family and S-SCAM in vitro through the canonical PDZ interaction.
Similar spatiotemporal expression patterns and complex
formation of IRSp53 and PSD-95 in brain
To determine the expression pattern of IRSp53 in brain, we gen-
erated polyclonal antibodies against full-length IRSp53 (aa
1–521; rabbit 1452 and guinea pig 1454). These antibodies recog-
nized two previously reported major IRSp53 bands (58 and 53
kDa) in brain samples (Abbott et al., 1999); these may represent
splice variants (Abbott et al., 1999; Okamura-Oho et al., 2001;
Alvarez et al., 2002). IRSp53 showed widespread expression in
various regions of the rat brain, including cortex, cerebellum,
hippocampus, and striatum (Fig. 2A), similar to PSD-95 (Cho et
al., 1992). During development, the expression levels of IRSp53
and PSD-95 sharply increased together during the second and
third postnatal weeks (Fig. 2B). In brain subcellular fractions,
IRSp53 and PSD-95 cofractionated into the crude synaptosomal
(P2) and synaptic membrane (LP1) fractions (Fig. 2C). In PSD
fractions, both IRSp53 and PSD-95 were enriched in all three
PSD fractions; IRSp53 was less enriched in the PSD III fraction
(Fig. 2D), suggesting that IRSp53 is less tightly associated with
the PSD than is PSD-95. Together, these results suggest that
IRSp53 and PSD-95 have similar spatiotemporal expression pat-
terns in brain.
To determine the formation of a complex between IRSp53
and PSD-95 in brain, we performed coimmunoprecipitation ex-
periments (Fig. 2E–J). When crude synaptosomal extracts of
adult rat brain were immunoprecipitated with IRSp53 antibod-
ies, PSD-95 and chapsyn-110, but not SAP97, SAP102, or
S-SCAM, were pulled down (Fig. 2E). IRSp53 antibodies pulled
down only a small fraction of Shank (Fig. 2E), a known binding
partner of IRSp53 (Bockmann et al., 2002; Soltau et al., 2002).
Control rabbit IgG did not bring down any protein tested (Fig.
2E). In the reciprocal coimmunoprecipitation experiments,
PSD-95 antibodies brought down IRSp53, along with NR2B (a
positive control) (Fig. 2F). Vinculin, a negative control, was not
pulled down by PSD-95 antibodies or guinea pig IgG (Fig. 2F).
Similarly, chapsyn-110, but not SAP97, SAP102, or S-SCAM an-
tibodies, brought down IRSp53 (Fig. 2G–J). Together, these re-
sults suggest that IRSp53 forms complexes with specific members
of the PSD-95 family in brain.
Colocalization of IRSp53 with PSD-95 in cultured neurons
and synaptic localization of IRSp53 in brain sections
Double immunofluorescence staining of cultured hippocampal
neurons revealed that IRSp53 was distributed to dendritic spines,
where it colocalized with PSD-95 (Fig. 3A). IRSp53 was also detected
in regions outside the synapse, including the cell body and the den-
dritic trunk (Fig. 3A), consistent with the observed presence of a
portion of IRSp53 in the extrasynaptic (S2) fraction (Fig. 2C).
In rat brain, at light microscopic level, IRSp53 was detected in
various brain regions, including cortex, hippocampus, and cere-
bellum (data not shown), consistent with our immunoblot re-
sults (Fig. 2A) and previous reports (Abbott et al., 1999; Bock-
mann et al., 2002). IRSp53 signals were detected in the cell bodies
and apical dendrites of principal neurons (e.g., pyramidal cells in
cortex and hippocampus and Purkinje cells in cerebellum) (see
Fig. 3, B and C, for images from the CA1 region of hippocampus).
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In forebrain, IRSp53 was not detected in
GABAergic local circuit neurons (data not
shown). Numerous puncta were positive
in the neuropil (Fig. 3D–F) (CA1 region).
Because satisfactory PSD-95 immuno-
staining of synapses in brain is difficult to
achieve (presumably because of poor anti-
body penetration) unless sections are pre-
treated with proteases (Fukaya and Wa-
tanabe, 2000), we did not try to detect
colocalization of IRSp53 and PSD-95. How-
ever, double immunofluorescence staining
for IRSp53 and the presynaptic marker syn-
aptophysin indicated that most of the
IRSp53 puncta were closely apposed to or
partially overlapped with synaptophysin
puncta (Fig. 3D–F), suggesting that IRSp53
concentrates at synaptic sites in brain. To-
gether, these results suggest that IRSp53 co-
localizes with PSD-95 at synaptic sites.
Ultrastructural localization of IRSp53
Despite growing recognition of the impor-
tance of IRSp53 in synaptic function, elec-
tron microscopic analysis of subcellular
distribution at the synapse has not been
reported. We used pre-embedding immu-
nogold EM to determine the ultrastructural
localization of IRSp53 in rat brain, focusing
on the CA1 region of hippocampus (Fig. 4).
Silver-enhanced immunogold particles were
most numerous at postsynaptic sites, where
they labeled both the PSD and spine cyto-
plasm (Fig. 4A–E). There was no obvious as-
sociation of immunogold particles with the
extrasynaptic spine membrane or intracyto-
plasmic membranes. Axon terminals also
exhibited occasional immunolabeling (Fig.
4B,C,E), but the label was predominantly
postsynaptic.
Both the C terminus and the SH3
domain are important for the synaptic
localization of IRSp53
IRSp53 is less tightly associated with the
PSD than is PSD-95 (Fig. 2D), suggesting
that the IRSp53–PSD-95 interaction may
play a role in the synaptic localization of
IRSp53. A previous study has shown that
the SH3 domain of IRSp53 binds to a
proline-rich region in Shank (Bockmann
et al., 2002; Soltau et al., 2002), suggesting
that the SH3 domain may be involved in
the postsynaptic localization of IRSp53.
To test these possibilities, we tested the
synaptic localization of the following
IRSp53 constructs (Fig. 5): IRSp53 WT,
IRSp53 C (a mutant lacking the PSD-95-
binding C-terminal residues), IRSp53 SH3 mut (I403P; an SH3
domain mutant incapable of binding Shank) (Fig. 5A), and
IRSp53 SH3 mut plus C (double mutant). When expressed in
cultured hippocampal neurons at 17 DIV and visualized at 19
DIV, IRSp53 WT showed significant accumulation at PSD-95-
positive dendritic spines (Fig. 5B). In contrast, IRSp53 C was
mainly diffusely distributed throughout the neuron (Fig. 5C).
IRSp53 SH3 mut showed a synaptic distribution between those of
IRSp53 WT and IRSp53 C (Fig. 5D). IRSp53 SH3 mut plus C
showed the lowest spine localization (Fig. 5E), indicating that the
Figure 1. IRSp53 interacts with all known PSD-95 family proteins and S-SCAM in yeast two-hybrid, GST pull-down, and
coimmunoprecipitation assays. A, Interaction of IRSp53 with PSD-95 family proteins and S-SCAM in the yeast two-hybrid assay.
PDZ domains from PSD-95 family proteins, S-SCAM, and other PDZ proteins in pGAD10 (prey vector) were tested for binding to
IRSp53 (aa 438 –521; wild type and the V521A mutant, in which the last Val residue was changed to Ala) in pBHA (bait vector) in
the yeast two-hybrid assay. -Galactosidase (-gal) activity: , 45 min; , 45–90 min; , 90 –240 min; , no
significant -gal activity. HIS3 activity: , 60%; , 30 – 60%; , 10 –30%; , no significant growth. B, Pull down
of PSD-95 family proteins and S-SCAM with GST-IRSp53 fusion proteins. GST fusion proteins of IRSp53 (aa 470 –521 and aa
470 –517, which lacks the last 4 residues) and GST alone were used to bring down the indicated proteins expressed in human
embryonic kidney 293T (HEK293T) cells. The precipitates were analyzed by immunoblotting with the indicated antibodies. C,
Lysates of HEK293T cells doubly transfected with Myc-PSD-95 plus HA-IRSp53WT or a mutant lacking the last four residues
(IRSp53C), or singly with Myc-PSD-95 were immunoprecipitated with HA antibodies and immunoblotted with HA (for IRSp53)
and Myc (for PSD-95) antibodies. Trans, Transfection; IP, immunoprecipitation. HA, Myc, FLAG, and EGFP represent epitope tags.
D–G, Chapsyn-110 ( D), SAP97 ( E), SAP102 ( F), and S-SCAM ( G) were similarly analyzed for coimmunoprecipitation with IRSp53.
872 • J. Neurosci., January 26, 2005 • 25(4):869 – 879 Choi et al. • IRSp53 Promotes Spine Morphogenesis
effects of the two mutations are additive. In these targeting exper-
iments, we coexpressed PSD-95, along with the IRSp53 con-
structs, so that the amount of PSD-95 or PSD-95-associated
Shank would not become a limiting factor for synaptic IRSp53
targeting. The expression levels of exogenous IRSp53 and PSD-95
were approximately two to three times higher than those of en-
dogenous proteins (fluorescent intensities in transfected neurons
relative to untransfected neurons: IRSp53 WT, 3.41  0.57;
IRSp53 SH3 mut, 3.85  0.12; IRSp53 C, 3.13  0.10; IRSp53
SH3 mut plus C; PSD-95, 3.54  0.58; n 	 5). In quantitative
analysis, IRSp53 C showed a synaptic localization (the ratio of
immunofluorescence intensity at a spine over that at an adjacent
dendritic trunk, 0.78  0.03; n 	 150 spines; *p  0.001) (Fig.
5F) that is significantly lower than IRSp53WT (2.15  0.02; n 	
150) (Fig. 5F). The synaptic accumulation
of IRSp53 SH3 mut (1.46  0.02; n 	 150;
*p  0.001) (Fig. 5F) was also significantly
lower than IRSp53 WT, although higher
than that of IRSp53C. Double-mutant
IRSp53 SH3 mut plus C displayed the
lowest synaptic localization (0.49  0.01;
n 	 150; *p  0.001 compared with WT)
(Fig. 5F). These results suggest that both
the C terminus and the SH3 domain of
IRSp53 are important determinants of its
synaptic localization.
Overexpression of IRSp53 in cultured
neurons selectively increases the density
of dendritic spines
Rac1/Cdc42 small GTPases have been
shown to regulate spine morphogenesis
(Luo et al., 1996; Nakayama et al., 2000;
Tashiro et al., 2000; Irie and Yamaguchi,
2002; Scott et al., 2003). Given that IRSp53
is a downstream effector of Rac1/Cdc42 in
non-neural cells, we tested whether
IRSp53 is involved in the regulation of
dendritic spines (Fig. 6). To this end, cul-
tured neurons at 15 DIV were transfected
with IRSp53, and the effects of IRSp53
overexpression on the density and mor-
phology of dendritic spines were analyzed
at 22 DIV. Interestingly, IRSp53 overex-
pression significantly increased the linear
density of dendritic spines (7.90  0.12 per
10 m dendrite; n 	 12 neurons; *p 
0.001) (Fig. 6B,D) compared with control
neurons transfected with EGFP alone
(4.99  0.52 per 10 m dendrite; n 	 14)
(Fig. 6A,D). In contrast, IRSp53 C did
not increase spine density in transfected
neurons (4.39  0.02; n 	 10; p 	 0.69
compared with EGFP alone controls) (Fig.
6C,D), indicating that synaptic localiza-
tion of IRSp53 is important for its spine-
promoting effects.
In contrast, morphometric analysis in-
dicated that the length of dendritic spines on
IRSp53-expressing neurons was not signifi-
cantly different (1.120.05m; n	10; p	
0.85) (Fig. 6E) from that of control neurons
(EGFP alone; 1.13  0.05 m; n 	 11) (Fig.
6E). Similarly, the width of the dendritic spines in IRSp53-
transfected neurons (0.63  0.01 m; n 	 10; p 	 0.58) was not
significantly different from that of control neurons (0.61  0.04
m; n 	 11) (Fig. 6F). IRSp53 C did not change spine mor-
phology (length, 1.16  0.05; n 	 15; p 	 0.92 compared with
EGFP alone controls; width, 0.77  0.03; n 	 15; p 	 0.82 com-
pared with EGFP alone controls) (Fig. 6E,F). Together, these
results indicate that IRSp53 selectively increases spine density
with minimal effects on spine size (length and width).
siRNA downregulation of IRSp53 decreases the density and
size of spines
Because IRSp53 overexpression in cultured neurons increases
spine density (Fig. 6), we tested whether IRSp53 is required for
Figure 2. Similar spatiotemporal expression patterns and complex formation of IRSp53 and PSD-95 in the brain. A, Expression
of IRSp53 in different brain regions. Membranes from various regions of adult rat brain were immunoblotted for IRSp53 and
-tubulin (control). The widespread expression of IRSp53 is similar to that of PSD-95 (Cho et al., 1992). Cb, Cerebellum; Ctx,
cortex; Hc, hippocampus; St, striatum; R, the rest of the brain. B, Similar developmental expression patterns of IRSp53 and PSD-95.
Membranes of rat brain at the indicated developmental stages were immunoblotted for IRSp53, PSD-95, and -tubulin (control).
E, Embryonic day; P, postnatal day; wk, week. C, Cofractionation of IRSp53 and PSD-95 in subcellular fractions of adult rat brain.
Synaptophysin (SynPhy) was probed as a control. H, Homogenates; P2, crude synaptosomes; S2, supernatant after P2 precipita-
tion; S3, cytosol; P3, light membranes; LP1, synaptosomal membranes; LS2, synaptosomal cytosol; LP2, synaptic vesicle-enriched
fraction. D, Coenrichment of IRSp53 and PSD-95 in PSD fractions. PSD fractions of adult rat brain extracted with Triton X-100 once
(PSD I), twice (PSD II), or with Triton X-100 and the strong detergent Sarcosyl (PSD III) were immunoblotted with IRSp53, PSD-95,
and synaptophysin antibodies. E, DOC extracts of the crude synaptosomal fraction of adult rat brain were immunoprecipitated
with IRSp53 antibodies or rabbit IgG (negative control) and immunoblotted with the indicated antibodies. Rb, Rabbit. F–J, The
same extracts were immunoprecipitated with PSD-95, chapsyn-110, SAP97, SAP102, and S-SCAM antibodies or control IgGs and
immunoblotted with the indicated antibodies. NR2B, NMDA glutamate receptor subunit 2 (positive control); Gp, guinea pig.
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the maintenance of normal spine density
(Fig. 7). To this end, we generated an
IRSp53 siRNA construct (pSUPER
IRSp53). When coexpressed with IRSp53
in heterologous cells, the expression of
IRSp53 was significantly reduced to 13.7 
1.2% of control levels (n 	 3; data not
shown). When this siRNA construct was
expressed in cultured neurons for 3 d
(from 13–16 DIV), the expression of en-
dogenous IRSp53 was markedly reduced
to 10.5  0.5% (n 	 7; *p  0.001) (Fig.
7A,C) of that in control neurons trans-
fected with the empty pSUPER vector (Fig.
7A,B).
When the effects of pSUPER IRSp53
were quantified, the linear density of den-
dritic spines on siRNA-transfected neu-
rons was significantly reduced (3.0  0.09
per 10 m dendrite; n 	 13; *p  0.001)
(Fig. 7C,D) compared with that of control
neurons transfected with the empty
pSUPER vector (4.30  0.14 per 10 m
dendrite; n 	 12) (Fig. 7B,D). Intrigu-
ingly, the length and width of the dendritic
spines on siRNA-transfected neurons were
also significantly reduced (length, 0.43 
0.02 m, n 	 10, *p  0.001; width, 0.24 
0.01 m, n 	 10, *p  0.001) (Fig. 7E,F)
compared with those of control neurons
(length, 0.88  0.03 m, n 	 10; width,
0.58  0.02 m, n 	 10) (Fig. 7 E, F ).
These results suggest that IRSp53 is re-
quired for the maintenance of both spine
density and size.
A dominant-negative IRSp53 SH3
mutant decreases the density and size
of spines
The present results suggest that IRSp53 is
important for spine regulation (Figs. 6, 7),
which prompts the question of just how
IRSp53 exerts its spine-promoting effects.
One possibility is that IRSp53, through its
SH3 domain, binds to various actin-
modulating proteins, including WAVE2,
Mena, and Shank. To test this hypothesis,
we used dominant-negative IRSp53 SH3
mutants that cannot link activated Rac1/
Cdc42 to SH3-binding downstream effec-
tors. When the IRSp53 SH3 mut (I403P)
(incapable of binding Shank, as described
above) was further tested for WAVE2
binding, there was no detectable interac-
tion with WAVE2, as inferred from the
lack of coimmunoprecipitation with the
SH3-binding proline-rich region of
WAVE2 in heterologous cells (Fig. 8A).
This suggests that the IRSp53 SH3 mut (I403P) is likely to block
the coupling of activated Rac1/Cdc42 with various downstream
SH3-binding proteins in a dominant-negative manner.
When IRSp53 SH3 mut was expressed in cultured neurons for
2 d (15–17 DIV), the density of dendritic spines was significantly
decreased (1.76  0.18 per 10 m dendrite; n 	 11; *p  0.001)
(Fig. 8C,D) compared with control neurons (4.82  0.36 per 10
m dendrite; n 	 12) (Fig. 8B,D). In addition, the length and
width of the dendritic spines on IRSp53 SH3 mut-transfected
neurons were significantly reduced (length, 0.63  0.02 m, n 	
Figure 3. Colocalization of IRSp53 with PSD-95 in cultured neurons and synaptic localization of IRSp53 in brain sections. A,
Colocalization of IRSp53 and PSD-95 in cultured neurons. Cultured hippocampal neurons (21 DIV) were doubly stained by immu-
nofluorescence for IRSp53 (A1; green) and PSD-95 (A2; red). The bottom panels are enlarged images of the small white boxes in
A1, A2, and A3. B, C, Expression pattern of IRSp53 (B; green) in the CA1 region of rat hippocampus. The Neuro Tracer dye (C; red)
was used to visualize all of the neurons. The arrows point to probable GABAergic interneurons. D–F, Colocalization of IRSp53 (D;
green) with synaptophysin (E; Syn; red). The inset in the merged image ( F) shows the close apposition or partial colocalization
between IRSp53 and synaptophysin. Scale bars: A, 20 m; B, 100 m; D, F, 10 m; inset, 2 m.
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9, *p  0.001; width, 0.38  0.01 m, n 	 9, *p  0.001) (Fig.
8E,F) compared with those of control neurons (length, 0.95 
0.02 m, n 	 10; width, 0.59  0.01 m, n 	 10) (Fig. 8E,F).
Notably, the expression of IRSp53 SH3 mut significantly reduced the
synaptic localization of Shank, one of the IRSp53 SH3-interacting
proteins, as determined by the spine/dendrite immunofluorescence
ratio (1.45  0.03 in IRSp53 SH3 mut-expressing neurons, n 	 120,
vs 2.63  0.05 in EGFP alone-expressing control neurons, n 	 120;
*p  0.001). A possible explanation for this is that Shank may de-
pend on IRSp53 interaction for its synaptic localization. Alterna-
tively, this effect may be caused by the general shrinkage of spines
associated with spine density reduction. Together, these results
suggest that the SH3 domain plays an important role in the
IRSp53-dependent regulation of dendritic spines.
A dominant-negative WAVE2 proline-rich region decreases
spine density and size
WAVE2, which binds to the IRSp53 SH3 via its proline-rich re-
gion, links activated Rac1 to the Arp2/3 actin nucleation
complex-dependent formation of lamellipodia in non-neural
cells (Miki et al., 2000; Miki and Takenawa, 2002). A useful dom-
inant negative that disrupts the functional connection between
IRSp53 and WAVE2 is a construct containing the proline-rich
region of WAVE2 (Miki et al., 2000). When this dominant-
negative construct (termed WAVE2 Pro) was expressed in cul-
tured neurons for 3 d (14 –17 DIV), spine density was signifi-
cantly decreased (3.01  0.10; n 	 11; *p  0.001) (Fig. 9B,C)
compared with control neurons transfected with EGFP alone
(5.06  0.15; n 	 10) (Fig. 9A,C). In addition, the length and
width of dendritic spines on WAVE2 Pro-transfected neurons
were significantly reduced (length, 0.60  0.04, n 	 9, *p  0.001;
width, 0.46  0.01, n 	 9, *p  0.001) (Fig. 9D,E), compared with
those of control neurons (length, 0.96  0.03, n 	 9; width, 0.55 
0.01, n 	 9) (Fig. 9D,E). WAVE2 Pro expression did not signifi-
cantly change the synaptic localization of IRSp53, as determined by
the spine/dendrite immunofluorescence ratio (1.28  0.03 in
WAVE2 Pro-expressing neurons, n 	 100, vs 1.31  0.02 in EGFP
alone-expressing control neurons, n 	 100;
p 	 0.81). A possible explanation for this is
that IRSp53, although its SH3 domain is
mainly blocked by WAVE2 Pro, can still be
targeted to synapses by the interaction of its
C terminus with PSD-95. Together, these re-
sults suggest that WAVE2 may be an impor-
tant mediator of IRSp53-dependent spine
regulation.
Discussion
Role of the IRSp53–PSD-95 interaction
in the synaptic localization of IRSp53
In the present study, we demonstrated that
IRSp53 interacts with PSD-95. This cor-
roborates the recent finding by Soltau et al.
(2004) that IRSp53 associates with PSD-
95. In addition, we found that IRSp53 as-
sociates with specific members of the
PSD-95 family (PSD-95 and chapsyn-110/
PSD-93) in brain (Fig. 2E–J). This in vivo
specificity could be attributable to differ-
ences in the spatiotemporal distribution
patterns of PSD-95 family proteins;
PSD-95 and chapsyn-110 are generally
synaptic, whereas SAP97 and SAP102 are
more widespread and implicated in traf-
ficking (Kim and Sheng, 2004). Previous work showed that a
member of the transmembrane AMPA receptor regulatory pro-
tein/stargazin family interacts specifically with PSD-95 and
chapsyn-110/PSD-93 (Dakoji et al., 2003). In addition, preferen-
tial associations have been demonstrated for PSD-95 and NR2A,
SAP102 and NR2B, and SAP97 and glutamate receptor 1 (Leo-
nard et al., 1998; Sans et al., 2000; Townsend et al., 2003). Thus,
our results contribute to the emerging notion that PSD-95 family
proteins have differential functions.
Our data indicate that both PSD-95 and Shank interactions
are required for synaptic IRSp53 localization (Fig. 5). Direct
comparison of the relative contribution of PSD-95 and Shank to
synaptic IRSp53 localization is difficult, because the relative
amounts of PSD-95, Shank, and IRSp53 in transfected neurons,
in addition to IRSp53 mutation/deletion, may alter the experi-
mental outcomes. However, in vivo coimmunoprecipitation re-
sults indicate that a much smaller portion of Shank, compared
with PSD-95, is in complex with IRSp53 (Fig. 2E). Because
PSD-95 is several fold more abundant than Shank1, as demon-
strated by a quantitative mass spectrometric analysis (Peng et al.,
2004), this result suggests that the majority of IRSp53 is associ-
ated with PSD-95 or that IRSp53 has a higher affinity for PSD-95
relative to Shank. Thus, it is likely that, in the PSD, the C-terminal
motif of IRSp53 is occupied by PSD-95, whereas the SH3 domain
may be free for other functions. The binding partners of this SH3
domain vary depending on the nature of the associated small
GTPases (Rac1 vs Cdc42). Thus, it would be advantageous for the C
terminus to engage in synaptic anchoring through the generally
strong PDZ interaction, whereas the SH3 domain serves as a versatile
Rac1/Cdc42-dependent switch that associates with various target
proteins for dynamic regulation of spine morphogenesis.
Role of IRSp53 in the regulation of dendritic spines
Our results indicate that IRSp53 overexpression selectively in-
creases spine density (Fig. 6). Conversely, siRNA-mediated
knock-down of IRSp53 reduces spine density and size (Fig. 7).
Figure 4. Immunogold-EM localization of IRSp53 in the CA1 stratum radiatum of rat hippocampus. Numerous IRSp53 immu-
nogold particles are associated with postsynaptic structures ( A–E). The arrows point to particles that localize within the PSD, and
arrowheads point to particles in the spine cytoplasm not associated with the PSD. An example of the association of IRSp53 particles
with perforated PSDs is shown (B; white arrowhead). A few particles can be seen at presynaptic sites (B, C, E). The stars indicate
immunopositive presynaptic terminals. Scale bars, 200 nm.
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IRSp53 SH3 mut and WAVE2 Pro reduce spine density and size
(Figs. 8, 9). Because IRSp53 links activated Rac1/Cdc42 to the
regulation of the actin cytoskeleton in non-neural cells (Miki et
al., 2000), these results suggest that IRSp53 may be an important
regulator of spine morphogenesis that acts downstream of Rac1/
Cdc42 in neurons, along with PAK and N-WASP, which have
been suggested to be downstream effectors of Rac1/Cdc42 in
EphB receptor-dependent spine morphogenesis (Irie and
Yamaguchi, 2002; Penzes et al., 2003).
The SH3 domain appears to be important in the spine-
promoting effects of IRSp53. In support of this, IRSp53 SH3 mut
and WAVE2 Pro reduced the spine density and size (Figs. 8, 9). In
addition, these dominant-negative effects resembled those seen
following siRNA-mediated knock-down of IRSp53, suggesting
that the IRSp53 effects are, in large part, mediated by the SH3
domain. Moreover, IRSp53 SH3 mut, despite containing the
N-terminal IMD domain that regulates the actin cytoskeleton
independent of the SH3 domain (Yamagishi et al., 2004), did not
have any spine-promoting effects (Fig. 8), suggesting that the
SH3 domain is more important. Together, these results strongly
suggest that IRSp53 links activated Rac1/Cdc42 to downstream
effectors through its SH3 domain.
The above results raise the question of how the IRSp53SH3
mediates the spine-promoting effects of IRSp53. One possibility
is that the IRSp53 SH3 domain interacts with actin regulating
downstream effectors. Known binding partners of the IRSp53
SH3 that are implicated in actin regulation include WAVE2,
Mena, and Shank (Miki et al., 2000; Krugmann et al., 2001; Bock-
mann et al., 2002; Soltau et al., 2002). We have shown here that
WAVE2 Pro reduces spine density and size (Fig. 9), suggesting
that the effects of IRSp53 may be mediated by WAVE2. WAVE2
is expressed in the brain at both the mRNA and protein levels
(Suetsugu et al., 1999) (J. Choi and E. Kim, unpublished results),
although its neuronal functions remain to be determined. The
Figure 5. Both the C terminus and the SH3 domain are important for the synaptic localiza-
tion of IRSp53. A, Loss of Shank binding in an IRSp53 mutant with a point mutation in the SH3
domain (IRSp53 SH3 mut; I403P). HEK293 cell lysates transfected with IRSp53 (WT or SH3 mut)
were pulled down by GST-Shank1 Pro (IRSp53-binding proline-rich region in Shank1) and im-
munoblotted with IRSp53 antibodies. B–E, Cultured hippocampal neurons (17 DIV) were co-
transfected with PSD-95-EGFP and HA-IRSp53 constructs; wild-type (IRSp53 WT; B), a PSD-95
binding-defective mutant that lacks the last four residues (IRSp53 C; C), a Shank binding-
defective mutant with a point mutation in the SH3 domain (IRSp53 SH3 mut; D), or a double
mutant (IRSp53 SH3 mut plus C; E). Transfected neurons were visualized by double immuno-
fluorescence staining for EGFP (for PSD-95) and HA (for IRSp53) at 19 DIV. To measure synaptic
localization, the immunofluorescence intensity of IRSp53 at a PSD-95-positive dendritic spine
was compared with that in an adjacent dendritic trunk. Scale bar, 20 m. F, quantitative
analysis of the synaptic localization of IRSp53.
Figure 6. Overexpression of IRSp53 selectively increases the density of dendritic spines in
cultured neurons. A–C, Effects of IRSp53 overexpression on dendritic spines. Cultured hip-
pocampal neurons (15 DIV) were transfected with IRSp53 plus EGFP ( B), IRSp53 C plus EGFP
( C), or EGFP alone (A; control) and visualized at 22 DIV by immunofluorescence staining for EGFP
( A–C) and IRSp53 (B, C). Only EGFP images are shown here for comparison. The bottom panels
are enlarged images of the small white boxes in the top panels. Scale bar, 20 m. D, Quantita-
tive analysis of the effects of IRSp53 overexpression on spine density. A significant change is
indicated by an asterisk. E, F, The cumulative frequency distribution of dendritic spine length ( E)
and width ( F) in transfected and control neurons.
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IRSp53-induced increase in spine density may be attributable to
the association of WAVE2 with the Arp2/3 actin nucleation com-
plex (Miki et al., 2000), which adds new branches to the sides of
existing actin filaments, causing dynamic extension of actin-
based structures. Conversely, the siRNA-induced reduction in
spine density and size may be attributable to spine shrinkage
caused by a lack of basal level activation of the Arp2/3 machinery.
However, it should be noted that IRSp53 SH3 mut (I403P) dis-
rupts the interaction of IRSp53 with both Shank and WAVE2
(Figs. 5A, 8A), suggesting that overexpression of WAVE2 Pro
dominant negative may block SH3 binding of WAVE2 as well as
other proteins. Another candidate that may mediate the IRSp53
effects is Mena, which is known to link Cdc42 activation to filop-
odia formation in non-neural cells (Govind et al., 2001; Krug-
mann et al., 2001) and is widely expressed in both developing
and, to a lesser degree, adult brain (Lanier et al., 1999). Mena is
required for the formation of growth cone filopodia and is impli-
cated in axon outgrowth and guidance (Lebrand et al., 2004), but
its role in spine morphogenesis remains an open question.
Shank may be the best characterized protein among the
known binding partners of the IRSp53 SH3. Shank has been
shown to regulate spine morphogenesis (Sala et al., 2001). In
particular, Shank acts in the maturation of spines, causing the
width and length of spines to increase without significantly affect-
ing spine density (Sala et al., 2001), which contrast to the selective
effects of IRSp53 on spine density in this study. Cortactin, a
Shank-associated protein that binds to F-actin and the Arp2/3
actin nucleation complex (Weed et al., 2000; Uruno et al., 2001),
has been shown to induce the formation of protrusions in aspiny
neurons and to be required for the maintenance of normal spine
density, as demonstrated by siRNA downregulation (Hering and
Sheng, 2003). However, the main effect of cortactin overexpres-
sion is to increase the length of spines but not their width and
density (Hering and Sheng, 2003), which again differs from the
spine density-specific effects of IRSp53 (Fig. 6). Another Shank-
associated protein that may contribute to the IRSp53-dependent
spine regulation is Abp1, an F-actin binding protein that is en-
Figure 7. siRNA downregulation of IRSp53 decreases the density and size of spines. A–C, The
effects of siRNA IRSp53 downregulation on dendritic spines. Cultured hippocampal neurons (13
DIV) were transfected with pSUPER IRSp53 plus EGFP-F (farnesylated EGFP), or empty pSUPER
plus EGFP-F, and visualized at 16 DIV by immunofluorescence staining for EGFP-F and IRSp53.
IRSp53 images were used to quantify the siRNA-induced downregulation of endogenous
IRSp53 expression ( A), and EGFP images were used to measure siRNA-induced changes in
dendritic spines. AU, Arbitrary unit. Scale bar, 20 m. D–F, Quantitative analysis of the effects
of siRNA IRSp53 downregulation on the density ( D) and size (length and width, E and F, respec-
tively) of dendritic spines.
Figure 8. A dominant-negative IRSp53 SH3 mutant decreases the density and size of spines.
A, Loss of WAVE2 interaction in IRSp53 SH3 mutant (I403P). Lysates of HEK293T cells transfected
with HA-IRSp53 (WT or SH3 mut) plus FLAG-WAVE2 Pro (proline-rich region; aa 273– 402) were
immunoprecipitated with FLAG antibodies and immunoblotted with IRSp53 and FLAG (for
WAVE2 Pro) antibodies. B, C, Cultured hippocampal neurons (15 DIV) were transfected with
IRSp53 SH3 mut plus EGFP ( C), or EGFP alone ( B), and visualized at 17 DIV by double immuno-
fluorescence staining for EGFP and IRSp53. Only EGFP images are shown for comparison. Scale
bar, 20 m. D–F, Quantitative analysis of the effects of IRSp53 SH3 mut expression on the
density ( D) and size (length and width, E and F, respectively) of spines.
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riched in the PSD (Qualmann et al., 2004). Notably, Abp1 is
recruited to spines by synaptic stimulation (Qualmann et al.,
2004), but the specific role for Abp1 in spine regulation is not
known. Thus, it remains to be determined whether Shank, cor-
tactin, and Abp1 mediate the effects of IRSp53.
Possible role of PSD-95 as an organizer of the Rac1 signaling
pathway in spines
Our data show that PSD-95 is important for the synaptic local-
ization of IRSp53, a downstream effector of activated Rac1/
Cdc42. PSD-95 is also required for the synaptic localization of
Kalirin-7 [Rac1 guanine nucleotide exchange factor (GEF)]
(Penzes et al., 2001). These results suggest that PSD-95, which
can form multimers (Kim et al., 1996; Hsueh et al., 1997; Chris-
topherson et al., 2003), may bring Kalirin-7 and IRSp53 close
together and mediate their possible functional coupling (activa-
tion of IRSp53 by Kalirin-7-activated Rac1). In addition, Shank,
which is linked to PSD-95 through guanylate kinase-associated
protein (GKAP) (Sheng and Kim, 2000), might interact with
PIX (Rac1/Cdc42 GEF) (Park et al., 2003) to bring PIX close to
IRSp53 for their possible functional coupling (activation of
IRSp53 by PIX-activated Rac1/Cdc42). Together, it appears that
the well-known PSD-95-GKAP-Shank axis may bring together
various Rac1/Cdc42-related signaling molecules (Kalirin-7,
PIX, and IRSp53) and coordinate their functional coupling to
regulate spine morphogenesis.
A correlation between PSD-95 assembly and spine morpho-
genesis has been demonstrated in several studies. Time-lapse im-
aging revealed that local assembly of PSD-95 spatiotemporally
correlates with spine formation (Okabe et al., 2001). PSD-95
overexpression in cultured neurons increases the density and size
of dendritic spines (El-Husseini et al., 2000). The degradation of
PSD-95 triggered by an inducible kinase results in the loss of
dendritic spines (Pak and Sheng, 2003). Considering the impor-
tant role of PSD-95 in synaptic IRSp53 localization and the role of
IRSp53 in spine regulation, dynamic changes in the synaptic con-
tent of PSD-95 during development and plasticity may be linked
via concomitant changes in synaptic IRSp53 levels to the regula-
tion of spine morphogenesis.
In conclusion, our results indicate that IRSp53 interacts with
two specific members of the PSD-95 family, PSD-95 and
chapsyn-110/PSD-93, and that this interaction is important for
synaptic IRSp53 localization. In addition, we have demonstrated
that IRSp53, a downstream effector of Rac1/Cdc42, regulates
spine morphogenesis through its SH3 domain. The next step is to
identify the molecular mechanisms acting downstream of IRSp53
and genetically confirm the roles for IRSp53 in the regulation of
dendritic spines.
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